Portage Biotech Inc. (PRTG)
USD 7.9
(-12.61%)
USD 7.9
(-12.61%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.29 Million | -12.07 Million | -6.76 Million | -4.28 Million | -3.71 Million | -858 Thousand |
| Net Income | -75.33 Million | -104.66 Million | -19.16 Million | -17.18 Million | -7.24 Million | -3.59 Million |
| Depreciation & Amortization | 54 Thousand | 1000.00 | - | 1.01 Million | 265 Thousand | - |
| Deferred income taxes | -10.56 Million | -17.88 Million | 4.39 Million | 2.44 Million | -265 Thousand | - |
| Stock-based compensation | 2.63 Million | 4.27 Million | 9.14 Million | 8.82 Million | 2.15 Million | 1.16 Million |
| Change in working capital | 982 Thousand | -10 Thousand | -461 Thousand | -744 Thousand | -114 Thousand | 715 Thousand |
| Other non-cash items | 70.71 Million | 106.2 Million | -670 Thousand | 1.35 Million | 1.49 Million | 853 Thousand |
| Investing Cash Flow | 2.81 Million | -617 Thousand | - | -860 Thousand | - | -446 Thousand |
| Investments in PPE | - | -3000.00 | - | 1 Million | - | - |
| Acquisitions | - | - | - | -1 Million | - | 504 Thousand |
| Investment purchases | - | - | - | -1 Million | - | -688 Thousand |
| Sales/Maturities of investments | 2.81 Million | - | - | 140 Thousand | - | - |
| Other Investing Activities | 2812.00 | -614 Thousand | - | -860.00 | - | -262 Thousand |
| Financing Cash Flow | 5.96 Million | -117 Thousand | 27.34 Million | 4.76 Million | 700 Thousand | -50 Thousand |
| Debt repayment | -40 Thousand | -2 Million | - | -1.02 Million | -300 Thousand | -50 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 670 Thousand | 2.98 Million | 29.09 Million | 6.98 Million | - | - |
| Other Financing Activities | 5.33 Million | -1.09 Million | -1.74 Million | -1.19 Million | 1 Million | - |
| Accounts receivables | -32 Thousand | -31 Thousand | 522 Thousand | -111 Thousand | -281 Thousand | 352 Thousand |
| Accounts payables | - | - | -1.21 Million | 880 Thousand | 167 Thousand | - |
| Inventory | - | - | 1.21 Million | -880 Thousand | 281 Thousand | - |
| Other working capital | 1.01 Million | 21 Thousand | -983 Thousand | -633 Thousand | -281 Thousand | 363 Thousand |
| Cash at beginning of period | 10.54 Million | 23.35 Million | 2.77 Million | 3.15 Million | 6.16 Million | 7.52 Million |
| Cash at end of period | 5.02 Million | 10.54 Million | 23.35 Million | 2.77 Million | 3.15 Million | 6.16 Million |
| Capital Expenditure | - | -3000.00 | - | 1 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.51 Million | -12.8 Million | 20.58 Million | -382 Thousand | -3.01 Million | -1.35 Million |
| Free Cash Flow | -14.29 Million | -12.07 Million | -6.76 Million | -3.28 Million | -3.71 Million | -858 Thousand |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.88 Million | -75.33 Million | -39.37 Million | -5.15 Million | -5.92 Million | -104.66 Million |
| Depreciation & Amortization | 13 Thousand | 54 Thousand | 15 Thousand | 14.99 Thousand | 11 Thousand | 1000.00 |
| Deferred income taxes | -87.6 Thousand | -10.56 Million | -9.41 Million | -915.7 Thousand | -148 Thousand | -17.88 Million |
| Stock-based compensation | 389 Thousand | 2.63 Million | 736 Thousand | 743 Thousand | 769 Thousand | 4.27 Million |
| Change in working capital | -302.28 Thousand | 982 Thousand | -223.63 Thousand | 858 Thousand | 650 Thousand | -10 Thousand |
| Other non-cash items | 22.6 Million | 70.71 Million | 44.92 Million | 580.36 Thousand | 1.19 Million | 106.2 Million |
| Investing Cash Flow | 2.81 Million | 2.81 Million | - | - | - | -617 Thousand |
| Investments in PPE | - | - | - | - | - | -3000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 2.81 Million | 2.81 Million | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -614 Thousand |
| Financing Cash Flow | 45.52 Thousand | 5.96 Million | 5.27 Million | 39.42 Thousand | 606 Thousand | -117 Thousand |
| Debt repayment | -12 Thousand | -40 Thousand | -11 Thousand | -10 Thousand | -7000.00 | -2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13.49 Thousand | 670 Thousand | -5877.26 | 49.43 Thousand | 632 Thousand | 2.98 Million |
| Other Financing Activities | 44.26 Thousand | 5.33 Million | 5.29 Million | -1000.00 | -19 Thousand | -1.09 Million |
| Accounts receivables | -527.89 Thousand | -32 Thousand | 209.7 Thousand | 353.19 Thousand | -17 Thousand | -31 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 225.61 Thousand | 1.01 Million | -433.34 Thousand | 504.81 Thousand | 667 Thousand | 21 Thousand |
| Cash at beginning of period | 5.34 Million | 10.54 Million | 3.44 Million | 7.69 Million | 10.54 Million | 23.35 Million |
| Cash at end of period | 5.02 Million | 5.02 Million | 5.34 Million | 3.44 Million | 7.69 Million | 10.54 Million |
| Capital Expenditure | - | - | - | - | - | -3000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -313 Thousand | -5.51 Million | 1.89 Million | -4.25 Million | -2.84 Million | -12.8 Million |
| Free Cash Flow | -3.21 Million | -14.29 Million | -3.33 Million | -4.29 Million | -3.45 Million | -12.07 Million |
NSRGF
RIWI
JEXYY
CYBERTECH
AVPMF
CHRB